Cha DR - Search Results

1

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.

Kim NH, Oh JH, Seo JA, Lee KW, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR. Kim NH, et al. Among authors: cha dr. Kidney Int. 2005 Jan;67(1):167-77. doi: 10.1111/j.1523-1755.2005.00067.x. Kidney Int. 2005. PMID: 15610240 Free article.

2

ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients.

Han SY, Kwon YJ, Jo SK, Shin JH, Cha DR, Cho WY, Pyo HJ, Kim HK. Han SY, et al. Among authors: cha dr. Korean J Intern Med. 2000 Jan;15(1):13-8. doi: 10.3904/kjim.2000.15.1.13. Korean J Intern Med. 2000. PMID: 10714086 Free PMC article.

3

Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease.

Adler SG, Feld S, Striker L, Striker G, LaPage J, Esposito C, Aboulhosn J, Barba L, Cha DR, Nast CC. Adler SG, et al. Among authors: cha dr. Kidney Int. 2000 May;57(5):2084-92. doi: 10.1046/j.1523-1755.2000.00058.x. Kidney Int. 2000. PMID: 10792628 Free article.

4

Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells.

Kim NH, Jung HH, Cha DR, Choi DS. Kim NH, et al. Among authors: cha dr. J Endocrinol. 2000 Jun;165(3):617-24. doi: 10.1677/joe.0.1650617. J Endocrinol. 2000. PMID: 10828845

5

Role of vascular endothelial growth factor in diabetic nephropathy.

Cha DR, Kim NH, Yoon JW, Jo SK, Cho WY, Kim HK, Won NH. Cha DR, et al. Kidney Int Suppl. 2000 Sep;77:S104-12. doi: 10.1046/j.1523-1755.2000.07717.x. Kidney Int Suppl. 2000. PMID: 10997699

6

alpha-Melanocyte stimulating hormone (MSH) decreases cyclosporine a induced apoptosis in cultured human proximal tubular cells.

Jo SK, Lee SY, Han SY, Cha DR, Cho WY, Kim HK, Won NH. Jo SK, et al. Among authors: cha dr. J Korean Med Sci. 2001 Oct;16(5):603-9. doi: 10.3346/jkms.2001.16.5.603. J Korean Med Sci. 2001. PMID: 11641530 Free PMC article.

7

Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy.

Adler SG, Kang SW, Feld S, Cha DR, Barba L, Striker L, Striker G, Riser BL, LaPage J, Nast CC. Adler SG, et al. Among authors: cha dr. Kidney Int. 2001 Dec;60(6):2330-6. doi: 10.1046/j.1523-1755.2001.00073.x. Kidney Int. 2001. PMID: 11737607 Free article.

8

Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.

Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR. Kim NH, et al. Among authors: cha dr. Diabet Med. 2004 Jun;21(6):545-51. doi: 10.1111/j.1464-5491.2004.01200.x. Diabet Med. 2004. PMID: 15154937

9

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.

Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH. Cha DR, et al. J Endocrinol. 2004 Oct;183(1):183-94. doi: 10.1677/joe.1.05647. J Endocrinol. 2004. PMID: 15525586

10

Effect of retinoic acid in experimental diabetic nephropathy.

Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK, Kang SW, Han DS, Han JY, Cha DR. Han SY, et al. Among authors: cha dr. Immunol Cell Biol. 2004 Dec;82(6):568-76. doi: 10.1111/j.1440-1711.2004.01287.x. Immunol Cell Biol. 2004. PMID: 15550114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters